Mirae Asset Global Investments
BIO icon

Mirae Asset Global Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mirae Asset Global Investments’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,102
Closed -$1.01M – 1597
2024
Q4 		$1.01M Sell
3,102
-297
-9% -$101K ﹤0.01% 816
2024
Q3 		$1.13M Sell
3,399
-897
-21% -$285K 0.01% 785
2024
Q2 		$1.17M Buy
+4,296
New +$1.25M 0.01% 715
2021
Q4 		– Sell
-7,977
Closed -$5.95M – 1588
2021
Q3 		$5.95M Buy
7,977
+187
+2% +$140K 0.02% 793
2021
Q2 		$5.02M Buy
7,790
+388
+5% +$236K 0.01% 815
2021
Q1 		$4.23M Buy
7,402
+95
+1% +$56.3K 0.01% 765
2020
Q4 		$4.26M Buy
7,307
+373
+5% +$212K 0.02% 691
2020
Q3 		$3.57M Buy
6,934
+1,858
+37% +$941K 0.02% 621
2020
Q2 		$2.29M Sell
5,076
-14,562
-74% -$6.43M 0.01% 669
2020
Q1 		$6.88M Buy
19,638
+3,036
+18% +$1.12M 0.05% 354
2019
Q4 		$6.14M Sell
16,602
-8,925
-35% -$3.15M 0.04% 462
2019
Q3 		$8.49M Buy
+25,527
New +$8.33M 0.06% 355

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mirae Asset Global Investments's BIO Position: Q1 2025 in Review

Mirae Asset Global Investments sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 3,102 shares — an estimated $1.01M sold.

Mirae Asset Global Investments first reported a position in BIO in Q3 2019 and held it in 12 quarters. The position peaked at $8.49M in Q3 2019. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Mirae Asset Global Investments reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 3,102 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $1.01M.
  • Mirae Asset Global Investments first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 12 quarters.
  • Mirae Asset Global Investments's Bio-Rad Laboratories Class A position peaked at $8.49M in Q3 2019.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Mirae Asset Global Investments's 13F filing for Q1 2025, filed 24 Apr 2025.